tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with Adenocystic Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalcanti de Araújo, V; Cyreno Oliveira, E; Furuse, C; Gastaldoni Jaeger, R; Morais Freitas, V; Nogueira da Gama de Souza, L | 1 |
1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and Adenocystic Carcinoma
| Article | Year |
|---|---|
Malignancy-related 67kDa laminin receptor in adenoid cystic carcinoma. Effect on migration and beta-catenin expression.
Topics: Antineoplastic Agents; Carcinoma, Adenoid Cystic; Cells, Cultured; Humans; Laminin; Neoplasm Proteins; Oligopeptides; Receptors, Laminin; Salivary Gland Neoplasms | 2007 |